BTCC / BTCC Square / Global Cryptocurrency /
KALA BIO Stock Surges 70% on AI Pivot, Eyes $180B Biotech Market

KALA BIO Stock Surges 70% on AI Pivot, Eyes $180B Biotech Market

Published:
2026-03-11 14:29:02
11
1
BTCCSquare news:

KALA BIO's shares skyrocketed 69.68% in pre-market trading after announcing its Researgency.ai platform launch in 14 days. The clinical-stage biotech company positions itself as the 'Palantir for biotech,' targeting AI's $180 billion healthcare opportunity.

Trading volume exploded to 51 million shares - 26x the 3-month average - as investors bet on the AI-powered transformation. The platform deploys autonomous agents for pharmaceutical workflows while maintaining traditional drug development pipelines.

This vertical AI play mirrors Palantir's government-tech success, now applied to life sciences. The market reaction suggests strong confidence in biotech's AI adoption curve, though the commercial execution remains unproven.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.